{"id":"W3170198976","doi":"10.1200/jco.2021.39.15_suppl.3005","title":"Initial results from a dose finding study of TNO155, a SHP2 inhibitor, in adults with advanced solid tumors.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Protein Tyrosine Phosphatases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis","keywords":"Medicine; Tolerability; Pharmacodynamics; Adverse effect; Pharmacokinetics; Internal medicine; Regimen; Oncology; Gastroenterology; Pharmacology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00241741,0.0009103704,0.001247972,0.0003385344,0.0002919053,0.000526838,0.0007154929,0.0008370166,0.003079867],"category_scores_gemma":[0.002010609,0.0003069238,0.00073312,0.0003342123,0.000496851,0.0005173233,0.0002611032,0.001570447,0.0007596145],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000833803,"about_ca_system_score_gemma":0.0008076479,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001052232,"about_ca_topic_score_gemma":0.001754288,"domain_scores_codex":[0.9992595,0.0003954807,0.00005829473,0.00009884789,0.00009732968,0.00009060866],"domain_scores_gemma":[0.9987226,0.0004493186,0.0002001987,0.0001174025,0.00009284159,0.0004175687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.3728916,0.1072596,0.03182418,0.0009407445,0.001431874,0.001837671,0.0009586708,0.005608703,0.2108981,0.0004527061,0.009298161,0.256598],"study_design_scores_gemma":[0.09972981,0.7892774,0.06877406,0.00006109378,0.000913528,0.001820422,0.0001100731,0.002023881,0.02313459,0.0002508497,0.0138618,0.00004241839],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.989189,0.002000437,0.001297901,0.0004205691,0.00004972019,0.001950838,0.001719034,0.00007565605,0.003296774],"genre_scores_gemma":[0.9866347,0.001562295,0.00372866,0.0007430167,0.0001465722,0.001218025,0.003778514,0.00003359333,0.002154605],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003079867,"threshold_uncertainty_score":0.01278466,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05399099045793521,"score_gpt":0.4246390614126213,"score_spread":0.3706480709546861,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}